Company

About Us

AlivaMab Discovery Services (ADS) sets its partners’ antibody discovery programs on the most efficient and de-risked path through discovery and development. Trusted by top-tier pharmaceutical and biotechnology companies, ADS delivers drug-quality, fully human antibodies on exceptional timelines. ADS achieves its partners’ design goals, from simple to extraordinarily challenging, through the generation and function-first screening of large, molecularly diverse panels of antibodies. ADS focuses on rapid and efficient delivery of antibodies, characterized for function, kinetics and developability, and engineering for advanced modalities, including multispecifics and CARs. The ADS team’s experience in antibody drug discovery and development comes from many of the world’s top 15 pharmaceutical companies, including AbbVie, AstraZeneca, Bristol Myers Squibb, Novartis, Pfizer and Roche/Genentech, and translates across more than 500 discovery programs and 35 clinical candidates. This experience, combined with the use of trusted, proven technologies, including Ablexis’ AlivaMab® Mouse platforms, ensures the highest probability of success.

Mission

To empower our partners with the most efficient and de-risked path through therapeutic antibody discovery and development.

Vision

A healthier world through partnerships that bring better medicines to patients faster.

Contact

AlivaMab Discovery Services, LLC
10581 Roselle Street, Suite 115
San Diego, CA 92121
1-858-866-9310
info@alivamab.com

Get in Touch